Your browser doesn't support javascript.
loading
Compliance with recommended cancer patient pathway timeframes and choice of treatment differed by cancer type and place of residence among cancer patients in Norway in 2015-2016.
Nilssen, Yngvar; Brustugun, Odd Terje; Eriksen, Morten Tandberg; Guren, Marianne G; Haug, Erik Skaaheim; Naume, Bjørn; Schlichting, Ellen; Møller, Bjørn.
Affiliation
  • Nilssen Y; Department of Registration, Cancer Registry of Norway, Oslo, Norway. ynni@kreftregisteret.no.
  • Brustugun OT; Department of Oncology, Drammen Hospital, Vestre Viken Hospital Trust, Drammen, Norway.
  • Eriksen MT; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
  • Guren MG; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
  • Haug ES; Division of Surgery, Inflammatory Diseases and Transplantation, Oslo University Hospital, Oslo, Norway.
  • Naume B; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
  • Schlichting E; Department of Oncology, Oslo University Hospital, Oslo, Norway.
  • Møller B; Section of Urology, Vestfold Hospital Trust, Tønsberg, Norway.
BMC Cancer ; 22(1): 220, 2022 Feb 28.
Article in En | MEDLINE | ID: mdl-35227226

Full text: 1 Database: MEDLINE Therapeutic Methods and Therapies TCIM: Plantas_medicinales Main subject: Patient Acceptance of Health Care / Patient Compliance / Critical Pathways / Time-to-Treatment / Neoplasms Type of study: Guideline / Prognostic_studies Country/Region as subject: Europa Language: En Journal: BMC Cancer Year: 2022 Type: Article Affiliation country: Norway

Full text: 1 Database: MEDLINE Therapeutic Methods and Therapies TCIM: Plantas_medicinales Main subject: Patient Acceptance of Health Care / Patient Compliance / Critical Pathways / Time-to-Treatment / Neoplasms Type of study: Guideline / Prognostic_studies Country/Region as subject: Europa Language: En Journal: BMC Cancer Year: 2022 Type: Article Affiliation country: Norway